Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Dr. Myron Czuczman highlighted the importance of the current U.S. Meals and Drug Administration (FDA) approval of Lymphir (denileukin diftitox-cxdl) for sufferers...
Throughout Cervical Most cancers Consciousness Month, Dr. Merieme Klobocista, a gynecologic surgical oncologist affiliated with Hackensack College Medical Heart and the John...
